Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations

被引:16
|
作者
Chen, Guangzhong [1 ,2 ]
Zheng, Meng [1 ,2 ]
Shu, Hang [1 ,2 ]
Zhan, Shengquan [1 ,2 ]
Wang, Hongqin [1 ,2 ]
Zhou, Dong [1 ,2 ]
Zeng, Shaojian [1 ,2 ]
Tang, Kai [1 ,2 ]
Feng, Lei [3 ]
机构
[1] Guangdong Gen Hosp, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Inst Neurosci, Guangzhou 510080, Guangdong, Peoples R China
[3] Univ Calif Los Angeles, David Geffen Sch Med, Div Intervent Neuroradiol, Los Angeles, CA 90095 USA
关键词
Cerebral arteriovenous malformation; Macrophage migration inhibitory factor; Caspase-3; Apoptosis; ENDOTHELIAL-CELLS; UP-REGULATION; EXPRESSION; ATHEROSCLEROSIS; ANGIOGENESIS; BRAIN; PATHWAY; DISEASE; TARGET; GENE;
D O I
10.1016/j.neulet.2011.12.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Purpose: To investigate the expression of macrophage migration inhibitory factor (MIF) in human brain arteriovenous malformations (AVM). Materials and methods: Twelve AVM specimens were obtained from patients who did not received preoperative embolization. MIF levels were measured by Western blot and matrix metalloproteinase 9 (MMP9) levels were measured by reverse transcription PCR The expression of MIF in brain AVMs was also evaluated by immunohistochemistry and was correlated with apoptosis and the expression of cleaved caspase-3 and MMP9. Results: The expression of MIF. MMP9, and cleaved caspase-3 was elevated in brain AVM vessels. High levels of MIF were primarily found in the endothelium and adventitia, whereas apoptotic cells were concentrated in the smooth muscle layer. Conclusions: Abnormal apoptosis may be involved in the pathogenesis of brain AVM. In addition, increased MIF expression could play an important role regulating the homeostasis of AVM vessels. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:84 / 88
页数:5
相关论文
共 50 条
  • [41] Macrophage migration inhibitory factor in human milk
    De Felice, C
    Magi, B
    Ietta, F
    Liberatori, S
    Paulesu, L
    PEDIATRIC RESEARCH, 2002, 52 (05) : 819 - 819
  • [42] Macrophage migration inhibitory factor in nodding syndrome
    Benedek, Gil
    El Latif, Mahmoud Abed
    Miller, Keren
    Rivkin, Mila
    Lasu, Ally Ahmed Ramadhan
    Edvardson, Shimon
    Galun, Eithan
    Levite, Mia
    HLA, 2022, 99 (05) : 543 - 543
  • [44] Macrophage migration inhibitory factor and oral cancer
    Franca, Cristiane M.
    Batista, Aline C.
    Borra, Ricardo C.
    Ventiades-Flores, Jose A.
    Mendona, Elismauro F.
    Deana, Alessandro M.
    Mesquita-Ferrari, Raquel A.
    Caly, Decio de Natali
    Rode, Sigmar de Mello
    Faria, Miriam R.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (05) : 368 - 373
  • [45] Receptor agonists of macrophage migration inhibitory factor
    Jorgensen, William L.
    Gandavadi, Sunilkumar
    Du, Xin
    Hare, Alissa A.
    Trofimov, Alexander
    Leng, Lin
    Bucala, Richard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 7033 - 7036
  • [46] Macrophage migration inhibitory factor in acute kidneyinjury
    Du, Yiwei
    Hao, Hao
    Ma, Heng
    Liu, Hongbao
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [47] Neuroimmunomodulation by macrophage migration inhibitory factor (MIF)
    Bucala, R
    NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 : 74 - 82
  • [48] MIGRATION INHIBITORY FACTOR AND MACROPHAGE BACTERICIDAL FUNCTION
    SIMON, HB
    SHEAGREN, JN
    INFECTION AND IMMUNITY, 1972, 6 (02) : 101 - &
  • [49] INHIBITION OF MACROPHAGE-MIGRATION INHIBITORY FACTOR
    HOUCK, JC
    CHANG, CM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1975, 148 (01): : 104 - 106
  • [50] Inhibition of Macrophage Migration Inhibitory Factor Reduces Diabetic Nephropathy in Type II Diabetes Mice
    Wang, Zhigang
    Wei, Meng
    Wang, Meng
    Chen, Lei
    Liu, Hua
    Ren, Yi
    Shi, Kehui
    Jiang, Hongli
    INFLAMMATION, 2014, 37 (06) : 2020 - 2029